Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Chronic Heart Failure

  Free Subscription


Articles published in Heart

Retrieve available abstracts of 75 articles:
HTML format
Text format



Single Articles


    October 2018
  1. MILANI GP, Bianchetti MG, Lava SA
    Measurement of sodium in heart failure.
    Heart. 2018;104:1724.
    PubMed     Text format    


    September 2018
  2. NTILOUDI D, Apostolopoulou S, Vasiliadis K, Frogoudaki A, et al
    Hospitalisations for heart failure predict mortality in pulmonary hypertension related to congenital heart disease.
    Heart. 2018 Sep 29. pii: heartjnl-2018-313613. doi: 10.1136/heartjnl-2018-313613
    PubMed     Text format     Abstract available


  3. LEE SE, Lee HY, Cho HJ, Choe WS, et al
    Coronary artery bypass graft versus percutaneous coronary intervention in acute heart failure.
    Heart. 2018 Sep 12. pii: heartjnl-2018-313242. doi: 10.1136/heartjnl-2018-313242
    PubMed     Text format     Abstract available


    August 2018
  4. SZE S, Pellicori P, Zhang J, Clark AL, et al
    Malnutrition, congestion and mortality in ambulatory patients with heart failure.
    Heart. 2018 Aug 18. pii: heartjnl-2018-313312. doi: 10.1136/heartjnl-2018-313312
    PubMed     Text format     Abstract available


  5. WOLFSON AM, Fong M, Grazette L, Rahman JE, et al
    Chronic heart failure management and remote haemodynamic monitoring.
    Heart. 2018 Aug 18. pii: heartjnl-2018-313397. doi: 10.1136/heartjnl-2018-313397
    PubMed     Text format     Abstract available


  6. HUANG W, Su L, Wu S, Xu L, et al
    Long-term outcomes of His bundle pacing in patients with heart failure with left bundle branch block.
    Heart. 2018 Aug 9. pii: heartjnl-2018-313415. doi: 10.1136/heartjnl-2018-313415.
    PubMed     Text format     Abstract available


    July 2018
  7. LYON AR
    Heart failure resulting from cancer treatment: still serious but an opportunity for prevention.
    Heart. 2018 Jul 4. pii: heartjnl-2018-313493. doi: 10.1136/heartjnl-2018-313493.
    PubMed     Text format    


  8. KUMAR N
    Does the purported mortality benefit of beta-blocker therapy in heart failure with a preserved ejection fraction apply to patients without prior myocardial infarction?
    Heart. 2018;104:1135.
    PubMed     Text format    


    June 2018
  9. OTTO CM
    Heartbeat: socioeconomic deprivation is associated with non-cardiovascular mortality in chronic heart failure patients.
    Heart. 2018;104:961-963.
    PubMed     Text format    


    May 2018
  10. NG AT, Duan L, Win T, Spencer HT, et al
    Maternal and fetal outcomes in pregnant women with heart failure.
    Heart. 2018 May 25. pii: heartjnl-2018-313156. doi: 10.1136/heartjnl-2018-313156
    PubMed     Text format     Abstract available


  11. NADRUZ W JR, West E, Sengelov M, Grove GL, et al
    Cardiovascular phenotype and prognosis of patients with heart failure induced by cancer therapy.
    Heart. 2018 May 15. pii: heartjnl-2018-313234. doi: 10.1136/heartjnl-2018-313234
    PubMed     Text format     Abstract available


    April 2018
  12. ROHDE LE, Beck-da-Silva L
    Alcohol and the heart: the good, the bad and the worse in heart failure.
    Heart. 2018 Apr 5. pii: heartjnl-2017-312924. doi: 10.1136/heartjnl-2017-312924.
    PubMed     Text format    


    March 2018
  13. BETTENCOURT P, Lourenco P
    Atrial fibrillation, a difficulty in the heart failure screening with natriuretic peptides.
    Heart. 2018 Mar 16. pii: heartjnl-2017-312910. doi: 10.1136/heartjnl-2017-312910
    PubMed     Text format    


  14. VAN DOORN S, Geersing GJ, Kievit RF, van Mourik Y, et al
    Opportunistic screening for heart failure with natriuretic peptides in patients with atrial fibrillation: a meta-analysis of individual participant data of four screening studies.
    Heart. 2018 Mar 16. pii: heartjnl-2017-312781. doi: 10.1136/heartjnl-2017-312781
    PubMed     Text format     Abstract available


  15. NADRUZ W JR, Gioli-Pereira L, Bernardez-Pereira S, Marcondes-Braga FG, et al
    Temporal trends in the contribution of Chagas cardiomyopathy to mortality among patients with heart failure.
    Heart. 2018 Mar 9. pii: heartjnl-2017-312869. doi: 10.1136/heartjnl-2017-312869.
    PubMed     Text format     Abstract available


  16. OTTO CM
    Heartbeat: Is there any effective therapy for heart failure with preserved ejection fraction?
    Heart. 2018;104:361-362.
    PubMed     Text format    


    February 2018
  17. COWIE MR, Zakeri R
    Preventing stroke in patients with heart failure: why are patients losing out?
    Heart. 2018 Feb 2. pii: heartjnl-2017-312862. doi: 10.1136/heartjnl-2017-312862.
    PubMed     Text format    


    January 2018
  18. WITTE KK, Patel PA, Walker AMN, Schechter CB, et al
    Socioeconomic deprivation and mode-specific outcomes in patients with chronic heart failure.
    Heart. 2018 Jan 31. pii: heartjnl-2017-312539. doi: 10.1136/heartjnl-2017-312539
    PubMed     Text format     Abstract available


  19. SQUIRE I
    Socioeconomic status and outcomes in heart failure with reduced ejection fraction.
    Heart. 2018 Jan 25. pii: heartjnl-2017-312814. doi: 10.1136/heartjnl-2017-312814
    PubMed     Text format    


  20. SAVARESE G, Sartipy U, Friberg L, Dahlstrom U, et al
    Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure.
    Heart. 2018 Jan 25. pii: heartjnl-2017-312720. doi: 10.1136/heartjnl-2017-312720
    PubMed     Text format     Abstract available


  21. WANG YC, Huang CW, Lin TW
    Acute heart failure with new-onset continuous murmur in a 26-year-old man.
    Heart. 2018 Jan 11. pii: heartjnl-2017-312506. doi: 10.1136/heartjnl-2017-312506
    PubMed     Text format     Abstract available


  22. ZAKERI R, Cowie MR
    Heart failure with preserved ejection fraction: controversies, challenges and future directions.
    Heart. 2018 Jan 5. pii: heartjnl-2016-310790. doi: 10.1136/heartjnl-2016-310790.
    PubMed     Text format     Abstract available


    December 2017
  23. MCMURRAY JJV, Trueman D, Hancock E, Cowie MR, et al
    Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction.
    Heart. 2017 Dec 21. pii: heartjnl-2016-310661. doi: 10.1136/heartjnl-2016-310661
    PubMed     Text format     Abstract available


  24. MARTENS P, Verbrugge FH, Nijst P, Dupont M, et al
    Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.
    Heart. 2017;103:1977-1984.
    PubMed     Text format     Abstract available


  25. ROUX V, Salaun E, Tribouilloy C, Hubert S, et al
    Coronary events complicating infective endocarditis.
    Heart. 2017;103:1906-1910.
    PubMed     Text format     Abstract available


  26. RAO P, Faddis M
    Cardiac resynchronisation therapy: current indications, management and basic troubleshooting.
    Heart. 2017;103:2000-2007.
    PubMed     Text format    


    November 2017
  27. KIM TH, Kim H, Kim IC, Yoon HJ, et al
    Heart rate at first postdischarge visit and outcomes in patients with heart failure.
    Heart. 2017 Nov 25. pii: heartjnl-2017-312364. doi: 10.1136/heartjnl-2017-312364
    PubMed     Text format     Abstract available


  28. MORTON G, Masters J, Cowburn PJ
    Multidisciplinary team approach to heart failure management.
    Heart. 2017 Nov 23. pii: heartjnl-2016-310598. doi: 10.1136/heartjnl-2016-310598
    PubMed     Text format    


  29. HUTCHINGS DC, Anderson SG, Trafford AW
    Phosphodiesterase-5 inhibitors as novel cardioprotective agents: have we reached threshold for large-scale clinical trials?
    Heart. 2017;103:1745.
    PubMed     Text format    


    October 2017
  30. LEE H, Lee SE, Park CS, Park JJ, et al
    Hyponatraemia and its prognosis in acute heart failure is related to right ventricular dysfunction.
    Heart. 2017 Oct 27. pii: heartjnl-2017-312084. doi: 10.1136/heartjnl-2017-312084
    PubMed     Text format     Abstract available


  31. CHOI KH, Lee GY, Choi JO, Jeon ES, et al
    Outcomes of de novo and acute decompensated heart failure patients according to ejection fraction.
    Heart. 2017 Oct 5. pii: heartjnl-2017-311813. doi: 10.1136/heartjnl-2017-311813.
    PubMed     Text format     Abstract available


  32. BOTTLE A, Kim D, Aylin P, Cowie MR, et al
    Routes to diagnosis of heart failure: observational study using linked data in England.
    Heart. 2017 Oct 5. pii: heartjnl-2017-312183. doi: 10.1136/heartjnl-2017-312183.
    PubMed     Text format     Abstract available


  33. PETRIE MC, Rocchiccioli P
    Coronary angiography in heart failure: when and why? Uncertainty reigns.
    Heart. 2017 Oct 5. pii: heartjnl-2017-312200. doi: 10.1136/heartjnl-2017-312200.
    PubMed     Text format    


  34. SINGH JSS, Burrell LM, Cherif M, Squire IB, et al
    Sacubitril/valsartan: beyond natriuretic peptides.
    Heart. 2017;103:1569-1577.
    PubMed     Text format     Abstract available


  35. OHUCHI H, Negishi J, Hayama Y, Miyazaki A, et al
    Renal resistive index reflects Fontan pathophysiology and predicts mortality.
    Heart. 2017;103:1631-1637.
    PubMed     Text format     Abstract available


    August 2017
  36. SCHNELL F, Donal E
    Pharmacological strategies in heart failure with preserved ejection fraction: time for an individualised treatment strategy?
    Heart. 2017 Aug 18. pii: heartjnl-2017-312119. doi: 10.1136/heartjnl-2017-312119
    PubMed     Text format    


  37. FERREIRA JP, Rossignol P, Demissei B, Sharma A, et al
    Coronary angiography in worsening heart failure: determinants, findings and prognostic implications.
    Heart. 2017 Aug 10. pii: heartjnl-2017-311750. doi: 10.1136/heartjnl-2017-311750
    PubMed     Text format     Abstract available


  38. ZHENG SL, Chan FT, Nabeebaccus AA, Shah AM, et al
    Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis.
    Heart. 2017 Aug 5. pii: heartjnl-2017-311652. doi: 10.1136/heartjnl-2017-311652.
    PubMed     Text format     Abstract available


    July 2017
  39. TUEGEL C, Bansal N
    Heart failure in patients with kidney disease.
    Heart. 2017 Jul 17. pii: heartjnl-2016-310794. doi: 10.1136/heartjnl-2016-310794
    PubMed     Text format     Abstract available


  40. SCHMIDT M
    Interaction between body mass index and physical fitness in primary heart failure prevention.
    Heart. 2017 Jul 17. pii: heartjnl-2017-311504. doi: 10.1136/heartjnl-2017-311504
    PubMed     Text format    


  41. MINAMINO-MUTA E, Kato T, Morimoto T, Taniguchi T, et al
    Impact of the left ventricular mass index on the outcomes of severe aortic stenosis.
    Heart. 2017 Jul 6. pii: heartjnl-2016-311022. doi: 10.1136/heartjnl-2016-311022.
    PubMed     Text format     Abstract available


  42. D'AMARIO D, Amodeo A, Adorisio R, Tiziano FD, et al
    A current approach to heart failure in Duchenne muscular dystrophy.
    Heart. 2017 Jul 1. pii: heartjnl-2017-311269. doi: 10.1136/heartjnl-2017-311269.
    PubMed     Text format     Abstract available


  43. GROGAN M, Dispenzieri A, Gertz MA
    Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response.
    Heart. 2017;103:1065-1072.
    PubMed     Text format     Abstract available


    June 2017
  44. FISHER SA, Doree C, Mathur A, Taggart DP, et al
    Cochrane Corner: stem cell therapy for chronic ischaemic heart disease and congestive heart failure.
    Heart. 2017 Jun 12. pii: heartjnl-2017-311684. doi: 10.1136/heartjnl-2017-311684
    PubMed     Text format    


  45. ROHDE LE, Biolo A
    The tip of the iceberg in the sub-Saharan Africa: unraveling the real world in the diagnosis and treatment of heart failure.
    Heart. 2017 Jun 5. pii: heartjnl-2017-311558. doi: 10.1136/heartjnl-2017-311558.
    PubMed     Text format    


    May 2017
  46. CRUMP C, Sundquist J, Winkleby MA, Sundquist K, et al
    Aerobic fitness, muscular strength and obesity in relation to risk of heart failure.
    Heart. 2017 May 12. pii: heartjnl-2016-310716. doi: 10.1136/heartjnl-2016-310716
    PubMed     Text format     Abstract available


  47. CARLSON S, Duber HC, Achan J, Ikilezi G, et al
    Capacity for diagnosis and treatment of heart failure in sub-Saharan Africa.
    Heart. 2017 May 10. pii: heartjnl-2016-310913. doi: 10.1136/heartjnl-2016-310913
    PubMed     Text format     Abstract available


  48. KUTYIFA V
    Gender-specific outcomes of cardiac resynchronisation therapy with or without defibrillator.
    Heart. 2017;103:732-733.
    PubMed     Text format    


  49. OTTO CM
    Heartbeat: Cardiac resynchronization therapy with or without defibrillation: are women different?
    Heart. 2017;103:727-728.
    PubMed     Text format    


    April 2017
  50. AMBALE-VENKATESH B, Yoneyama K, Sharma RK, Ohyama Y, et al
    Left ventricular shape predicts different types of cardiovascular events in the general population.
    Heart. 2017;103:499-507.
    PubMed     Text format     Abstract available


    March 2017
  51. OTTO CM
    Heartbeat: Diabetes and heart failure.
    Heart. 2017;103:327-328.
    PubMed     Text format    


  52. OTTO CM
    Heartbeat:Blood urea nitrogen to creatinine ratio predicts outcome in acute heart failure.
    Heart. 2017;103:399-401.
    PubMed     Text format    


    February 2017
  53. ROSMINI S, Biagini E, O'Mahony C, Bulluck H, et al
    Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy.
    Heart. 2017;103:300-306.
    PubMed     Text format     Abstract available


    January 2017
  54. BARRA S, Providencia R, Duehmke R, Boveda S, et al
    Sex-specific outcomes with addition of defibrillation to resynchronisation therapy in patients with heart failure.
    Heart. 2017 Jan 19. pii: heartjnl-2016-310677. doi: 10.1136/heartjnl-2016-310677
    PubMed     Text format     Abstract available


    December 2016
  55. SCHRANZ D, Akintuerk H, Voelkel NF
    'End-stage' heart failure therapy: potential lessons from congenital heart disease: from pulmonary artery banding and interatrial communication to parallel circulation.
    Heart. 2016 Dec 23. pii: heartjnl-2015-309110. doi: 10.1136/heartjnl-2015-309110
    PubMed     Text format     Abstract available


  56. KINUGASA Y, Yamamoto K
    The challenge of frailty and sarcopenia in heart failure with preserved ejection fraction.
    Heart. 2016 Dec 9. pii: heartjnl-2016-309995. doi: 10.1136/heartjnl-2016-309995.
    PubMed     Text format     Abstract available


  57. OTTO CM
    Heartbeat: Heart failure and obstructive lung disease: are beta-blockers underused?
    Heart. 2016;102:1855-1856.
    PubMed     Text format    


  58. BURCHILL LJ
    Heart transplantation in adult congenital heart disease.
    Heart. 2016;102:1871-1877.
    PubMed     Text format     Abstract available


    November 2016
  59. INGLIS SC, Clark RA, Dierckx R, Prieto-Merino D, et al
    Structured telephone support or non-invasive telemonitoring for patients with heart failure.
    Heart. 2016 Nov 18. pii: heartjnl-2015-309191. doi: 10.1136/heartjnl-2015-309191
    PubMed     Text format    


    October 2016
  60. CHIMURA M, Onishi T, Tsukishiro Y, Sawada T, et al
    Longitudinal strain combined with delayed-enhancement magnetic resonance improves risk stratification in patients with dilated cardiomyopathy.
    Heart. 2016 Oct 31. pii: heartjnl-2016-309746. doi: 10.1136/heartjnl-2016-309746
    PubMed     Text format     Abstract available


  61. TAJIK AA, Dickstein K
    What constitutes optimal neurohumoral antagonism in chronic heart failure?
    Heart. 2016 Oct 14. pii: heartjnl-2015-308039. doi: 10.1136/heartjnl-2015-308039
    PubMed     Text format    


  62. NUNEZ J
    Blood urea nitrogen to creatinine ratio in acute heart failure: an old concept brought to reality?
    Heart. 2016 Oct 14. pii: heartjnl-2016-310536. doi: 10.1136/heartjnl-2016-310536
    PubMed     Text format    


  63. CEDIEL G, Gonzalez-Del-Hoyo M, Carrasquer A, Sanchez R, et al
    Outcomes with type 2 myocardial infarction compared with non-ischaemic myocardial injury.
    Heart. 2016 Oct 14. pii: heartjnl-2016-310243. doi: 10.1136/heartjnl-2016-310243
    PubMed     Text format     Abstract available


  64. BANSAL N, Szpiro A, Masoudi F, Greenlee RT, et al
    Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators.
    Heart. 2016 Oct 14. pii: heartjnl-2016-309842. doi: 10.1136/heartjnl-2016-309842
    PubMed     Text format     Abstract available


    September 2016
  65. RAHIMI K
    The long and unfinished journey of hyperglycaemia and heart failure research.
    Heart. 2016 Sep 29. pii: heartjnl-2016-310336. doi: 10.1136/heartjnl-2016-310336
    PubMed     Text format    


  66. NAIR A, Sajeev CG, Muneer K
    A case of recent myocardial infarction with cardiac failure.
    Heart. 2016 Sep 29. pii: heartjnl-2016-309715. doi: 10.1136/heartjnl-2016-309715
    PubMed     Text format     Abstract available


  67. MATSUE Y, van der Meer P, Damman K, Metra M, et al
    Blood urea nitrogen-to-creatinine ratio in the general population and in patients with acute heart failure.
    Heart. 2016 Sep 22. pii: heartjnl-2016-310112. doi: 10.1136/heartjnl-2016-310112
    PubMed     Text format     Abstract available


  68. NASR E, Ibrahim M, Yacoub M
    Heart failure in a neonate with multiple cardiac masses.
    Heart. 2016 Sep 21. pii: heartjnl-2016-310251. doi: 10.1136/heartjnl-2016-310251
    PubMed     Text format     Abstract available


  69. OU SM, Chen HT, Kuo SC, Chen TJ, et al
    Dipeptidyl peptidase-4 inhibitors and cardiovascular risks in patients with pre-existing heart failure.
    Heart. 2016 Sep 19. pii: heartjnl-2016-309687. doi: 10.1136/heartjnl-2016-309687
    PubMed     Text format     Abstract available


  70. SKRTIC S, Cabrera C, Olsson M, Schnecke V, et al
    Contemporary risk estimates of three HbA1c variables in relation to heart failure following diagnosis of type 2 diabetes.
    Heart. 2016 Sep 19. pii: heartjnl-2016-309806. doi: 10.1136/heartjnl-2016-309806
    PubMed     Text format     Abstract available


  71. KIM CH, Al-Kindi SG, Jandali B, Askari AD, et al
    Incidence and risk of heart failure in systemic lupus erythematosus.
    Heart. 2016 Sep 9. pii: heartjnl-2016-309561. doi: 10.1136/heartjnl-2016-309561.
    PubMed     Text format     Abstract available


    June 2016
  72. DHILLON A, Khanna A, Randhawa MS, Cywinski J, et al
    Perioperative outcomes of patients with hypertrophic cardiomyopathy undergoing non-cardiac surgery.
    Heart. 2016 Jun 10. pii: heartjnl-2016-309442. doi: 10.1136/heartjnl-2016-309442
    PubMed     Text format     Abstract available


    February 2016
  73. LAM CS, Lund LH
    Microvascular endothelial dysfunction in heart failure with preserved ejection fraction.
    Heart. 2016;102:257-9.
    PubMed     Text format    


  74. OTTO CM
    Heartbeat: Microvascular dysfunction in heart failure with preserved ejection fraction.
    Heart. 2016;102:255-6.
    PubMed     Text format    


    December 2015
  75. HODES AR, Tichnell C, Te Riele AS, Murray B, et al
    Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy.
    Heart. 2015 Dec 30. pii: heartjnl-2015-308624. doi: 10.1136/heartjnl-2015-308624
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: